乳腺癌：基础与临床的转化（上、下册）

作者: 沈镇宙主编 , 邵志敏

出版社: 上海交通大学出版社

出版时间: 2016-09

版次: 1

ISBN: 9787313157805

定价: 268.00

装帧: 精装

开本: 16开

纸张: 胶版纸

页数: 884页

字数: 816千字

分类: 医药卫生

1 张插图图片

46人买过

《乳腺癌：基础与临床的转化》是“转化医学出版工程˙肿瘤系列”之一。主要涵盖了国内外对乳腺癌基础与临床相关领域内的各方面研究。包括乳腺癌的基础研究，如二代测序、干细胞、低氧代谢、分子通路、microRNA等；临床研究，如分子亚型分型分治、治疗方式、康复护理等。尤其着重于基础与临床的转化型研究，如基因诊断、干细胞研究，以及手术、药物和新辅助治疗方法在乳腺癌精准诊断和治疗中的应用，探讨了乳腺癌治疗从循证医学到精准医学的转变。本书《乳腺癌：基础与临床的转化》适合对象包括乳腺诊疗和研究领域相关的医务工作者、教师、研究生以及其他感兴趣的人群等。     邵志敏教授，首批教育部长江学者特聘教授，复旦大学特聘教授。现任复旦大学肿瘤研究所长、乳腺癌研究所所长，大外科主任兼乳腺外科主任，中国抗癌协会乳腺癌专业委员会名誉主任委员，中华医学会肿瘤学分会副主任委员，上海市抗癌协会乳腺癌专业委员会名誉主任委员，上海市医学会肿瘤专科委员会主任委员，第八届亚洲乳腺癌协会主席、St.Gallen乳腺癌大会专家团成员。主要从事乳腺癌的临床和基础研究，建立适合中国人群的早期筛查和诊疗流程，开展临床试验提高乳腺癌患者的预后，科研重点为乳腺癌的转化研究和乳腺癌转移机制研究等。已发表有关乳腺癌研究的论著近350篇，其中SCI收录100余篇，被世界医学文献引用逾3 000次，主编专著4本。多次荣获卫生部科技进步一等奖，上海市科技进步一、二、三等奖，国家科技进步二等奖，教育部科技进步一、二等奖项。由其领衔的团队分别入选教育部创新团队、上海市乳腺肿瘤重点实验室及上海市教委“重中之重临床医学中心B类”项目、上海市重要疾病联合攻关项目。先后主持国家杰出青年科研基金、国家自然科学基金、国家“十五”攻关课题、卫生部临床重点项目、“211”工程II、“985”项目、“973”课题及其他省部级项目30余项。

      INTRODUCTION

      Pro. Shao Zhimin, distinguished professor of Fudan University, is one of the first batch of distinguished professor of Chang Jiang Scholars. He presently serves as the director of Fudan University Cancer Institute and Breast Cancer Institute; chairman of department of surgery and department of breast surgery in Fudan University Cancer Hospital; Honorary chairman of Breast Cancer Society, China Anti-Cancer Association; Vice chairman of oncology branch committee, Chinese Medical Association; Honorary chairman of Breast Cancer Society, Shanghai Anti-Cancer Association; Chairman of oncology branch committee, Shanghai Medical Association; Chairman of the Eighth Asian Breast Cancer Society, and member of the St. Gallen international breast cancer consensus panel.

      Prof.Shao engages in clinical and basic research for breast cancer. He established an early screening and diagnosis process for the Chinese population, and carry out clinical trials to improve the prognosis of breast cancer patients. His researches mainly focus on s breast cancer translational research and mechanisms of metastasis of breast cancer. He has published nearly 350 papers about breast cancer research, and over 100 of which is included by SCI and has been cited for more than 3000 times by the world’s medical literature. He also published four books about breast disease. Dr.Shao has been awarded with Prize of Science and Technology Progress of Ministry of Health, Grade I; Prize of Science and Technology Progress of Shanghai Government, Grade I, II and III; National Prize Prize of Science and Technology Progress, Grade II; and Prize of Science and Technology Progress of Ministry of Education, Grade I, II. He was chosen as leader of selected innovative team of the Ministry of Education, Shanghai Key Laboratory of Breast Malignancy Tumor, Shanghai Education Commission Type B Program of the Priority Project of Clinical Medical Centers, and the Shanghai Joint Research Project of Major Diseases. He hosted and actualized in over 30 key research projects including National Excellent Youth Foundation, National Science Foundation, Key Project of National 10th 5-year Plan, Priority project on clinical medicine of Ministry of Health, “211” Project phase II, “985” Project, “973” Project, and other provincial or ministerial projects. 第一章乳腺癌：从循证医学到精准医学

第二章中国乳腺癌的临床研究

第三章中国乳腺癌的基础研究

第四章二代测序在乳腺癌基础与临床研究中的价值

第五章乳腺肿瘤干细胞的研究

第六章低氧、肿瘤代谢和乳腺癌

第七章 P13K—AKT—mTOR通路与乳腺癌的耐药机制

第八章 CDKs抑制剂在乳腺癌中的研究

第九章 microRNA、IncRNA和乳腺癌

第十章调控乳腺癌发生、发展的细胞因子

第十一章乳腺癌骨转移的基础与转化研究

第十二章乳腺癌的药物治疗

第十三章乳腺癌的免疫治疗

第十四章乳腺癌的影像学诊断

第十五章进展期乳腺癌的外科治疗

第十六章乳腺癌的延长内分泌治疗

第十七章前哨淋巴结活检的临床应用

第十八章复发转移乳腺癌内分泌治疗策略

第十九章遗传性乳腺癌的研究

第二十章早期乳腺癌保乳手术的争议及中国经验

第二十一章乳腺癌的放射治疗

第二十二章 HER—2阳性乳腺癌的研究

第二十三章乳腺癌的靶向治疗

第二十四章三阴性乳腺癌的潜在靶点

第二十五章三阴性乳腺癌的全程管理

第二十六章乳腺癌辅助和新辅助治疗的优化

第二十七章乳腺癌患者的术后康复

索引
内容简介:
《乳腺癌：基础与临床的转化》是“转化医学出版工程˙肿瘤系列”之一。主要涵盖了国内外对乳腺癌基础与临床相关领域内的各方面研究。包括乳腺癌的基础研究，如二代测序、干细胞、低氧代谢、分子通路、microRNA等；临床研究，如分子亚型分型分治、治疗方式、康复护理等。尤其着重于基础与临床的转化型研究，如基因诊断、干细胞研究，以及手术、药物和新辅助治疗方法在乳腺癌精准诊断和治疗中的应用，探讨了乳腺癌治疗从循证医学到精准医学的转变。本书《乳腺癌：基础与临床的转化》适合对象包括乳腺诊疗和研究领域相关的医务工作者、教师、研究生以及其他感兴趣的人群等。
作者简介:
    邵志敏教授，首批教育部长江学者特聘教授，复旦大学特聘教授。现任复旦大学肿瘤研究所长、乳腺癌研究所所长，大外科主任兼乳腺外科主任，中国抗癌协会乳腺癌专业委员会名誉主任委员，中华医学会肿瘤学分会副主任委员，上海市抗癌协会乳腺癌专业委员会名誉主任委员，上海市医学会肿瘤专科委员会主任委员，第八届亚洲乳腺癌协会主席、St.Gallen乳腺癌大会专家团成员。主要从事乳腺癌的临床和基础研究，建立适合中国人群的早期筛查和诊疗流程，开展临床试验提高乳腺癌患者的预后，科研重点为乳腺癌的转化研究和乳腺癌转移机制研究等。已发表有关乳腺癌研究的论著近350篇，其中SCI收录100余篇，被世界医学文献引用逾3 000次，主编专著4本。多次荣获卫生部科技进步一等奖，上海市科技进步一、二、三等奖，国家科技进步二等奖，教育部科技进步一、二等奖项。由其领衔的团队分别入选教育部创新团队、上海市乳腺肿瘤重点实验室及上海市教委“重中之重临床医学中心B类”项目、上海市重要疾病联合攻关项目。先后主持国家杰出青年科研基金、国家自然科学基金、国家“十五”攻关课题、卫生部临床重点项目、“211”工程II、“985”项目、“973”课题及其他省部级项目30余项。

      INTRODUCTION

      Pro. Shao Zhimin, distinguished professor of Fudan University, is one of the first batch of distinguished professor of Chang Jiang Scholars. He presently serves as the director of Fudan University Cancer Institute and Breast Cancer Institute; chairman of department of surgery and department of breast surgery in Fudan University Cancer Hospital; Honorary chairman of Breast Cancer Society, China Anti-Cancer Association; Vice chairman of oncology branch committee, Chinese Medical Association; Honorary chairman of Breast Cancer Society, Shanghai Anti-Cancer Association; Chairman of oncology branch committee, Shanghai Medical Association; Chairman of the Eighth Asian Breast Cancer Society, and member of the St. Gallen international breast cancer consensus panel.

      Prof.Shao engages in clinical and basic research for breast cancer. He established an early screening and diagnosis process for the Chinese population, and carry out clinical trials to improve the prognosis of breast cancer patients. His researches mainly focus on s breast cancer translational research and mechanisms of metastasis of breast cancer. He has published nearly 350 papers about breast cancer research, and over 100 of which is included by SCI and has been cited for more than 3000 times by the world’s medical literature. He also published four books about breast disease. Dr.Shao has been awarded with Prize of Science and Technology Progress of Ministry of Health, Grade I; Prize of Science and Technology Progress of Shanghai Government, Grade I, II and III; National Prize Prize of Science and Technology Progress, Grade II; and Prize of Science and Technology Progress of Ministry of Education, Grade I, II. He was chosen as leader of selected innovative team of the Ministry of Education, Shanghai Key Laboratory of Breast Malignancy Tumor, Shanghai Education Commission Type B Program of the Priority Project of Clinical Medical Centers, and the Shanghai Joint Research Project of Major Diseases. He hosted and actualized in over 30 key research projects including National Excellent Youth Foundation, National Science Foundation, Key Project of National 10th 5-year Plan, Priority project on clinical medicine of Ministry of Health, “211” Project phase II, “985” Project, “973” Project, and other provincial or ministerial projects.
目录:
第一章乳腺癌：从循证医学到精准医学

第二章中国乳腺癌的临床研究

第三章中国乳腺癌的基础研究

第四章二代测序在乳腺癌基础与临床研究中的价值

第五章乳腺肿瘤干细胞的研究

第六章低氧、肿瘤代谢和乳腺癌

第七章 P13K—AKT—mTOR通路与乳腺癌的耐药机制

第八章 CDKs抑制剂在乳腺癌中的研究

第九章 microRNA、IncRNA和乳腺癌

第十章调控乳腺癌发生、发展的细胞因子

第十一章乳腺癌骨转移的基础与转化研究

第十二章乳腺癌的药物治疗

第十三章乳腺癌的免疫治疗

第十四章乳腺癌的影像学诊断

第十五章进展期乳腺癌的外科治疗

第十六章乳腺癌的延长内分泌治疗

第十七章前哨淋巴结活检的临床应用

第十八章复发转移乳腺癌内分泌治疗策略

第十九章遗传性乳腺癌的研究

第二十章早期乳腺癌保乳手术的争议及中国经验

第二十一章乳腺癌的放射治疗

第二十二章 HER—2阳性乳腺癌的研究

第二十三章乳腺癌的靶向治疗

第二十四章三阴性乳腺癌的潜在靶点

第二十五章三阴性乳腺癌的全程管理

第二十六章乳腺癌辅助和新辅助治疗的优化

第二十七章乳腺癌患者的术后康复

索引

查看详情

乳腺癌：基础与临床的转化（上、下册）

内容简介:

作者简介:

目录: